Standout Papers

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer 2021 2026 2022 20241.4k
  1. Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer (2021)
    Oliver Sartor, Johann S. de Bono et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 57 standout
Sub-graph 1 of 22

Citing Papers

Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Prostate Cancer
2025 Standout
1 intermediate paper

Works of Nitin Vaishampayan being referenced

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout

Author Peers

Author Last Decade Papers Cites
Nitin Vaishampayan 1081 988 542 12 1.6k
James B. Stubbs 747 1225 340 42 1.8k
Euloge Kpamegan 1259 1010 572 11 1.7k
Chandler H. Park 1083 989 570 20 1.5k
Neil A. Petry 361 883 314 50 1.8k
Stephen Adler 497 636 230 50 1.6k
Bipin M. Mehta 1005 224 564 20 1.9k
Bernhard M. Dohmen 553 1172 455 18 2.0k
Terry L. Sharp 289 971 263 33 1.7k
Martin Büchert 349 424 470 42 2.0k
Hans Wester 201 798 344 29 1.7k

All Works

Loading papers...

Rankless by CCL
2026